Analyst	Recommendation	Action	Price target	Projected	Date
Chad Beynon Macquarie	Buy	Upgraded	$7.00	+84.7%	10/25/2026
Josh Nichols B. Riley Securities	Buy	Maintained	$8.75	+130.9%	10/23/2026
Barry Jonas Truist Financial	Buy	Maintained	$8.00	+111.1%	10/20/2026
Jordan Bender Citizens JMP	Buy	Maintained	$9.00	+137.5%	10/13/2026
Hamed Khorsand BWS Financial	Hold	Downgraded	-	-	09/29/2026
Ryan Sigdahl Craig-Hallum	Buy	Maintained	-	-	03/09/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	86.20M	77.20M	57.20M	60.80M
Cost of goods sold	25.70M	17.70M	11.20M	12.20M
Cost of revenue	25.70M	17.70M	11.20M	12.20M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	31.50M	19.70M	23.90M	23.20M
Operating expense	44.70M	33.00M	36.40M	37.70M
Total operating expenses	70.40M	50.70M	47.60M	49.90M
Operating income	15.80M	26.50M	9.60M	10.90M
Other non operating income	-	-	-	-
EBT including unusual items	-2.60M	900.00K	-1.20M	600.00K
EBT excluding unusual items	3.30M	15.80M	-900.00K	1.40M
Income tax expense	-700.00K	8.10M	-700.00K	400.00K
Effective tax rate	26.92%	900.00%	58.33%	66.67%
Other operating expenses	-	-	-	-
Net income	-1.90M	-7.20M	-500.00K	200.00K
Net profit margin	-2.20%	-9.33%	-0.87%	0.33%
Earnings per share	0.28	-0.18	-0.02	0.05
Interest and investment income	-	-	-	-
Interest expense	-12.50M	-10.70M	-10.50M	-9.50M
Net interest expenses	-12.50M	-10.70M	-10.50M	-9.50M
Depreciation and amortization charges	13.20M	13.30M	12.50M	14.50M
EBITDA	29.00M	33.50M	22.10M	25.40M
Gain or loss from assets sale	-	6.60M	-	-

Ask anything